Aeos Labs is the third laboratory in the state to earn certification for testing of medical cannabis. Steep Hill Hawai‘i on O‘ahu received certification last year in July and Pharmlabs Hawai‘i, LLC on Maui was certified last year in October.
The VCT-1 is the first in a line of next-generation extraction technology, creating the closest thing to vaping or smoking, only cleaner, at lower cost, superior quality, and with precision dosing.
Supercritical CO2 removes the concern of toxic solvent residues and is generally recognized as safe by the FDA and EFSA.
Cannabinoids have demonstrated potential as treatments for liver diseases such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and fibrosis.
The dominance of high THC, low CBD cannabis strains indicates how criminalisation and a lack of regulation steer the black market.
The process, which was developed and tested in the Netherlands under strict regulatory guidelines, involves the growing of selected cannabis plants at a cGMP facility followed by extraction of the cannabinoid molecules from cannabis flowers.
For the first time, a major scientific study has confirmed what cannabis advocates have known for decades: that cannabis can be a safe and effective palliative treatment in patients suffering from the debilitating effects of cancer.
Nearly 63% of patients also reported reduced or eliminated opioid usage after six months of using medical cannabis.
Around one third of patients treated for epilepsy continue to have seizures, this study finds that CBD could help.